Warnakulasuriya S. Global epidemiology of oral and oropharyngeal cancer. Oral Oncol. 2009;45(4-5):309–16.
Article
Google Scholar
Szafarowski T, Szczepanski MJ. Cancer stem cells in head and neck squamous cell carcinoma. Otolaryngol Pol. 2014;68(3):105–11.
Article
Google Scholar
Liao CT, Chang JT, Wang HM, Ng SH, Hsueh C, Lee LY, et al. Surgical outcome of T4a and resected T4b oral cavity cancer. Cancer. 2006;107(2):337–44.
Article
Google Scholar
Gatti L, Zunino F. Overview of tumor cell chemoresistance mechanisms. Methods Mol Med. 2005;111:127–48.
CAS
PubMed
Google Scholar
Gottesman MM. Mechanisms of cancer drug resistance. Annu Rev Med. 2002;53(1):615–27.
Article
CAS
Google Scholar
Li JZ, Gao W, Chan JY, Ho WK, Wong TS. Hypoxia in head and neck squamous cell carcinoma. ISRN Otolaryngol. 2012 Oct 16;2012:708974.
PubMed
PubMed Central
Google Scholar
Carmeliet P, Jain RK. Principles and mechanisms of vessel normalization for cancer and other angiogenic diseases. Nat Rev Drug Discov. 2011;10(6):417–27.
Article
CAS
Google Scholar
Lee DJ, Kang SW. Reactive oxygen species and tumor metastasis. Mol Cells. 2013;35(2):93–8 (Retracted article).
Article
CAS
Google Scholar
Kusumbe AP, Bapat SA. Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy. Cancer Res. 2009;69(24):9245–53.
Article
CAS
Google Scholar
Shanbhag VL. Understanding cancer stem cells in head and neck cancer: an insight from oral medicine point of view. Oncobiol Targets. 2015;2:24–8.
Article
Google Scholar
Prince ME, Sivanandan R, Kaczorowski A, Wolf GT, Kaplan MJ, Dalerba P, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci. 2007;104(3):973–8.
Article
CAS
Google Scholar
Garg M. Potential therapeutic applications of microRNAs in response to DNA damage in cancer stem cells.J. Stem Cells. 2011;6(2):51–65.
Google Scholar
Huppi K, Volfovsky N, Mackiewicz M, Runfola T, Jones TL, Martin SE, et al. MicroRNAs and genomic instability. Semin Cancer Biol. 2007;17(1):65–73.
Article
CAS
Google Scholar
Kulshreshtha R, Ferracin M, Negrini M, Calin GA, Davuluri RV, Ivan M. Regulation of microRNA expression: the hypoxic component. Cell Cycle. 2007;6(12):1426–31.
Article
CAS
Google Scholar
Gee HE, Camps C, Buffa FM, Patiar S, Winter SC, Betts G, et al. Hsa-Mir-210 is a marker of tumor hypoxia and a prognostic factor in head and neck cancer. Cancer. 2010;116(9):2148–58.
PubMed
Google Scholar
Chan YC, Banerjee J, Choi SY, Sen CK. miR-210: The master hypoxamir. Microcirculation. 2012;19(3):215–23.
Article
CAS
Google Scholar
Tan DX, Manchester LC, Esteban-Zubero E, Zhou Z, Reiter RJ. Melatonin as a potent and inducible endogenous antioxidant: synthesis and metabolism. Molecules. 2015;20(10):18886–906.
Article
CAS
Google Scholar
Lin PY, Yu CH, Wang JT, Chen HH, Cheng SJ, Kuo MY, Chiang CP. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. J Oral Pathol Med. 2008;37(1):18–25.
Article
Google Scholar
de Almeida Chuffa LG, Fioruci BA, Seiva FRF. Melatonin and their protective role on oxidative cell damage: interplay between oxidative stress and tumorigenesis. In: Castroviejo DA, Rusanova I, Escames G, editors. New Developments in Melatonin Research: Spain, Nova Publishers; 2013. p. 121–38.
Kim JH, Park SG, Song SY, Kim JK, Sung JH. Reactive oxygen species responsive miR-210 regulates proliferation and migration of adipose derived stem cells via PTPN2. Cell Death Dis. 2013;4:e588.
Article
CAS
Google Scholar
Rossi L, Bonmassar E, Faraoni I. Modification of miR gene expression pattern in human colon cancer cells following exposure to 5-fluorouracil in vitro. Pharmacol Res. 2007;56(3):248–53.
Article
CAS
Google Scholar
Shah MY, Pan X, Fix LN, Farwell MA, Zhang B. 5-fluorouracil drug alters the microrna expression profiles in MCF-7 breast cancer cells. J Cell Physiol. 2011;226(7):1868–78.
Article
CAS
Google Scholar
Jung B, Ahmad N. Melatonin in cancer management: progress and promise. Cancer Res. 2006;66(20):9789–93.
Article
CAS
Google Scholar
Gonçalves N, Colombo J, Lopes JR, Gelaleti GB, Moschetta MG, Sonehara NM, et al. Effect of melatonin in epithelial mesenchymal transition markers and invasive properties of breast cancer stem cells of canine and human cell lines. PLoS One. 2016;11(3):e0150407.
Article
Google Scholar
Koçak N, Dönmez H, Yildirim İH. Effects of melatonin on apoptosis and cell differentiation in MCF-7 derived cancer stem cells. Cell Mol Biol (Noisy-le-grand). 2018;64(12):56–61.
Article
Google Scholar
Akbarzadeh M, Movassaghpour AA, Ghanbari H, Kheirandish M, Maroufi NZ, Rahbarghazi R, et al. c. Sci Rep. 2017; 7: 17062.
Ullmann P, Qureshi-Baig K, Rodriguez F, Ginolhac A, Nonnenmacher Y, Ternes D, et al. Hypoxia-responsive miR210 promotes self-renewal capacity of colon tumor-initiating cells by repressing ISCU and by inducing lactate production. Oncotarget. 2016;7(40):65455–70.
Article
Google Scholar
Tang T, Yang Z, Zhu Q, Wu Y, Sun K, Alahdal M, et al. Up-regulation of miR-210 induced by a hypoxic microenvironment promotes breast cancer stem cell metastasis, proliferation, and self-renewal by targeting E-cadherin. FASEB J. 2018:fj201801013R.
Welsh M, Mangravite L, Medina MW, Tantisira K, Zhang W, Huang RS, et al. Pharmacogenomic discovery using cell-based models. Pharmacol Rev. 2009;61(4):413–29.
Article
CAS
Google Scholar
Voskoglou-Nomikos T, Pater JL, Seymour L. Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models. Clin Cancer Res. 2003;9(11):4227–39.
PubMed
Google Scholar
Zeeberg BR, Kohn KW, Kahn A, Larionov V, Weinstein JN, Reinhold W, et al. Concordance of gene expression and functional correlation patterns across the NCI-60 cell lines and the Cancer Genome Atlas glioblastoma samples. PLoS One. 2012;7(7):e40062.
Article
CAS
Google Scholar